why choose us

First received: August 30, 2023

Clinical Trial: CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Non-hodgkin Lymphoma

Study Type: INTERVENTIONAL


Official Title: A Phase I Study of Bivalent CD79b and CD19 Directed CAR T Cells in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma

Brief Summary: This research study involves the study of CD79b-19 CAR T cells for treating people with relapsed/refractory Non-Hodgkin Lymphoma and to understand the side effects when treated with CD79b-19 CAR T cells.This research study involves the study drugs:CD79b-19 CAR T cellsFludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part of lymphodepleting process

Read more